COLOMBO, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 169
EU - Europa 122
AS - Asia 38
AF - Africa 4
Totale 333
Nazione #
US - Stati Uniti d'America 164
DE - Germania 29
SE - Svezia 21
CN - Cina 14
PL - Polonia 13
IE - Irlanda 11
FR - Francia 10
IT - Italia 10
UA - Ucraina 10
IR - Iran 8
JP - Giappone 7
GB - Regno Unito 6
CA - Canada 5
MA - Marocco 4
RU - Federazione Russa 4
FI - Finlandia 3
HK - Hong Kong 3
SG - Singapore 3
GR - Grecia 2
PT - Portogallo 2
ID - Indonesia 1
IN - India 1
NO - Norvegia 1
TW - Taiwan 1
Totale 333
Città #
Ann Arbor 21
Woodbridge 19
Fairfield 14
Jacksonville 14
Kraków 13
Dublin 11
Frankfurt am Main 10
New York 8
St Louis 8
Ashburn 7
Houston 6
Cambridge 5
Chandler 5
Dearborn 5
Wilmington 5
Cagliari 4
Princeton 4
Seattle 4
Tangier 4
Alexandria 3
Hong Kong 3
Los Angeles 3
Milan 3
Nagasaki 3
Tokyo 3
Turlock 3
Athens 2
Beijing 2
Chicago 2
Exton 2
Jiaxing 2
Kansas City 2
Lachine 2
Liverpool 2
Paris 2
Rochester 2
Andover 1
Bengaluru 1
Boardman 1
Brooklyn 1
Changsha 1
Chiba 1
Falls Church 1
Fremont 1
Glasgow 1
Gorle 1
Gostar 1
Guangzhou 1
Hebei 1
Helsinki 1
Honolulu 1
Jakarta 1
Kilburn 1
Kunming 1
Lawrence 1
Leawood 1
Montreal 1
Montréal 1
Mountain View 1
Nanchang 1
Ningbo 1
Oslo 1
Shenyang 1
Singapore 1
Taipei 1
Tianjin 1
Toronto 1
University Park 1
Zhengzhou 1
Totale 241
Nome #
Functional and structural characterization of the slitrk2 172
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 161
Totale 333
Categoria #
all - tutte 838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202070 6 1 3 3 5 6 10 2 18 1 4 11
2020/202130 5 1 4 3 1 0 3 3 2 3 3 2
2021/202216 0 1 4 3 0 0 1 1 1 0 3 2
2022/202339 6 15 6 1 1 4 0 4 0 0 2 0
2023/202481 1 2 2 0 8 14 13 11 10 12 6 2
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 333